Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07814742) titled 'Effectiveness of UrDiaCare' on Sept. 4. Study Type: Interventional Study D... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815431) titled 'MC1R Mutations Associated With Red Hair and Perioperative Anesthesia Complica... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816237) titled 'A Multicenter, Randomized, Open-Label, Positive Controlled Phase III Study to... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07810907) titled 'Effect of Resuscitation on Gastric Emptying Using POCUS in Pediatric Trauma P... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811544) titled 'Immune Evaluation for Postoperative Sepsis-AKI' on Sept. 4. Study Type: Obse... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811778) titled 'Transcutaneous Electrical Acupoint Stimulation Combined With Exposure and Res... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811882) titled 'Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812077) titled 'A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism,... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812129) titled 'Insulin Eye Drops and Epithelial Healing After Corneal Cross-linking' on Sept... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812181) titled 'An Open-Label Phase II Feasibility Study for the Use of Ublituximab in Adults... Read More